The Impact of OnabotulinumtoxinA vs. Placebo on Efficacy Outcomes in Headache Day Responder and Nonresponder Patients with Chronic Migraine

Stephen D. Silberstein, Hans Christoph Diener, David W. Dodick, Aubrey Manack Adams, Ronald E. DeGryse, Richard B. Lipton

Research output: Contribution to journal › Article › peer-review

Fingerprint

Dive into the research topics of 'The Impact of OnabotulinumtoxinA vs. Placebo on Efficacy Outcomes in Headache Day Responder and Nonresponder Patients with Chronic Migraine'. Together they form a unique fingerprint.

Medicine & Life Sciences